Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Amber Bangma"'
Autor:
Shixian Hu, Arno R. Bourgonje, Ranko Gacesa, Bernadien H. Jansen, Johannes R. Björk, Amber Bangma, Iwan J. Hidding, Hendrik M. van Dullemen, Marijn C. Visschedijk, Klaas Nico Faber, Gerard Dijkstra, Hermie J. M. Harmsen, Eleonora A. M. Festen, Arnau Vich Vila, Lieke M. Spekhorst, Rinse K. Weersma
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-14 (2024)
Abstract Disrupted host-microbe interactions at the mucosal level are key to the pathophysiology of IBD. This study aimed to comprehensively examine crosstalk between mucosal gene expression and microbiota in patients with IBD. To study tissue-specif
Externí odkaz:
https://doaj.org/article/7d585f4cd17d4027b8c1cce58bfea380
Autor:
Femke M. Prins, Iwan J. Hidding, Marjolein A.Y. Klaassen, Valerie Collij, Johannes P.D. Schultheiss, Werna T.C. Uniken Venema, Amber Bangma, Jurne B. Aardema, Bernadien H. Jansen, Wout G.N. Mares, Ben J.M. Witteman, Eleonora A.M. Festen, Gerard Dijkstra, Marijn C. Visschedijk, Herma H. Fidder, Arnau Vich Vila, Bas Oldenburg, Ranko Gacesa, Rinse K. Weersma
Publikováno v:
Gut Microbes, Vol 16, Iss 1 (2024)
Emerging evidence suggests the gut microbiome’s potential in predicting response to biologic treatments in patients with inflammatory bowel disease (IBD). In this prospective study, we aimed to predict treatment response to vedolizumab and ustekinu
Externí odkaz:
https://doaj.org/article/75c0bb382cf0416fa8df443a241eb914
Autor:
Naomi Karmi, Amber Bangma, Lieke M Spekhorst, Hendrik M van Dullemen, Marijn C Visschedijk, Gerard Dijkstra, Rinse K Weersma, Michiel D Voskuil, Eleonora A M Festen
Publikováno v:
PLoS ONE, Vol 16, Iss 9, p e0256860 (2021)
BackgroundAnti-tumour necrosis factor alpha (TNFα) therapy is widely used in the management of Crohn's disease (CD) and ulcerative colitis (UC). However, up to a third of patients do not respond to induction therapy and another third of patients los
Externí odkaz:
https://doaj.org/article/7e6c3516725d43519dd43909c7f20bd4
Autor:
Shixian Hu, Arno R. Bourgonje, Ranko Gacesa, Bernadien H. Jansen, Johannes R. Björk, Amber Bangma, Iwan J. Hidding, Hendrik M. van Dullemen, Marijn C. Visschedijk, Klaas Nico Faber, Gerard Dijkstra, Hermie J. M. Harmsen, Eleonora A. M. Festen, Arnau Vich Vila, Lieke M. Spekhorst, Rinse K. Weersma
Dysregulation of gut mucosal host–microbe interactions is a central feature of inflammatory bowel disease (IBD). To study tissue-specific interactions, we performed transcriptomic (RNA-seq) and microbial (16S-rRNA-seq) profiling of 696 intestinal b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1a69ea117c56f6920813a2cbfc3a6a55
https://doi.org/10.1101/2022.06.04.494807
https://doi.org/10.1101/2022.06.04.494807
Autor:
Werna T. Uniken Venema, Pauline Lanting, Michiel Voskuil, Lude Franke, Eleonora A. M. Festen, Shixian Hu, Amber Bangma, Gerard Dijkstra, Harm Brugge, Rinse K. Weersma
Publikováno v:
Alimentary Pharmacology & Therapeutics, 51(11), 1105-1115. Wiley
Alimentary Pharmacology & Therapeutics
Alimentary Pharmacology & Therapeutics
BACKGROUND: High inter-individual variability in therapeutic response to drugs used in the management of Inflammatory Bowel Disease (IBD) leads to high morbidity and high costs. Genetic variants predictive of thiopurine-induced myelosuppression, thio
Autor:
Amber Bangma, Hendrik M. van Dullemen, Naomi Karmi, Lieke M. Spekhorst, Gerard Dijkstra, Michiel Voskuil, Marijn C. Visschedijk, Rinse K. Weersma, Eleonora A. M. Festen
Publikováno v:
PLoS ONE, Vol 16, Iss 9, p e0256860 (2021)
PLoS ONE, 16(9):e0256860. PUBLIC LIBRARY SCIENCE
PLoS ONE
PLoS ONE, 16(9):e0256860. PUBLIC LIBRARY SCIENCE
PLoS ONE
Background Anti-tumour necrosis factor alpha (TNFα) therapy is widely used in the management of Crohn’s disease (CD) and ulcerative colitis (UC). However, up to a third of patients do not respond to induction therapy and another third of patients
Publikováno v:
World Journal of Gastroenterology
Inflammatory bowel disease (IBD) is a chronic and heterogeneous intestinal inflammatory disorder. The medical management of IBD aims for long-lasting disease remission to prevent complications and disease progression. Early introduction of immunosupp
Publikováno v:
Gastroenterology, 160(7), 2621-2622. W B SAUNDERS CO-ELSEVIER INC
Gastroenterology
Gastroenterology
Autor:
Amber Bangma, Johannes R. Björk, Rinse K. Weersma, W. Uniken Venema, A Vich Vila, M Van der Wijst, Gursah Kats-Ugurlu, E Festen
Publikováno v:
Journal of Crohn's and Colitis. 15:S043-S043
Background Primary sclerosing cholangitis (PSC) is an inflammatory disorder of the bile ducts. The etiology of PSC is unknown, but it is hypothesized that intestinal barrier dysfunction, as seen in inflammatory bowel disease (IBD), plays a role. Roug